These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3698061)
1. Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo. Sinar DR; Bozymski EM; Blackshear JL Clin Ther; 1986; 8(2):157-63. PubMed ID: 3698061 [TBL] [Abstract][Full Text] [Related]
2. Effect of potassium chloride supplements on upper gastrointestinal mucosa. McMahon FG; Ryan JR; Akdamar K; Ertan A Clin Pharmacol Ther; 1984 Jun; 35(6):852-5. PubMed ID: 6734038 [TBL] [Abstract][Full Text] [Related]
3. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial. McMahon FG; Ryan JR; Akdamar K; Ertan A Lancet; 1982 Nov; 2(8307):1059-61. PubMed ID: 6127542 [TBL] [Abstract][Full Text] [Related]
4. The effects of five potassium chloride preparations on the upper gastrointestinal mucosa in healthy subjects receiving glycopyrrolate. Alsop WR; Moore JG; Rollins DE; Tolman KG J Clin Pharmacol; 1984; 24(5-6):235-9. PubMed ID: 6747020 [TBL] [Abstract][Full Text] [Related]
5. Mucosal irritant potential of a potassium-sparing diuretic and of wax-matrix potassium chloride. Ryan JR; McMahon FG; Akdamar K; Ertan A; Agrawal N Clin Pharmacol Ther; 1984 Jan; 35(1):90-3. PubMed ID: 6690174 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ulcerogenic effect of potassium chloride by endoscopy and fecal blood loss. Lech Y; Hey H; Jørgensen F; Matzen P; Ostergaard O J Clin Pharmacol; 1987 Mar; 27(3):206-9. PubMed ID: 3680575 [TBL] [Abstract][Full Text] [Related]
9. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971 [TBL] [Abstract][Full Text] [Related]
10. Gastroscopic localization of a microencapsulated KCl preparation in the human stomach. Graham DY; Smith JL; Jones RD; Rakhit A; Tipnis V; Hurley ME Gastrointest Endosc; 1987 Jun; 33(3):220-3. PubMed ID: 3297914 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of patients' preference of two potassium chloride supplements: Slow-K and K-Dur. Pietro DA; Davidson L Clin Ther; 1990; 12(5):431-5. PubMed ID: 2268865 [TBL] [Abstract][Full Text] [Related]
12. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study. Lanza F; Sahba B; Schwartz H; Winograd S; Torosis J; Quan H; Reyes R; Musliner T; Daifotis A; Leung A Am J Gastroenterol; 2002 Jan; 97(1):58-64. PubMed ID: 11808969 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. Rainsford KD; Stetsko PI; Sirko SP; Debski S J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509 [TBL] [Abstract][Full Text] [Related]
14. A comparison of wax matrix and microencapsulated potassium chloride in relation to upper gastrointestinal illness requiring hospitalization. Jick H; Jick SS; Walker AM; Stergachis A Pharmacotherapy; 1989; 9(4):204-6. PubMed ID: 2771805 [TBL] [Abstract][Full Text] [Related]
15. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen. Lanza FL; Codispoti JR; Nelson EB Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328 [TBL] [Abstract][Full Text] [Related]
16. What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations. Graham DY; Smith JL; Bouvet AA J Pharm Sci; 1990 May; 79(5):420-4. PubMed ID: 2352162 [TBL] [Abstract][Full Text] [Related]
18. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers. Müller P; Simon B Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519 [TBL] [Abstract][Full Text] [Related]
19. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
20. Irritative properties of two clinical potassium chloride formulations on duodenal mucosa of the cat and esophageal mucosa of the opossum. Alphin RS; O'Dell SW; Sancilio LF; Ward JW Dig Dis Sci; 1984 Jun; 29(6):508-12. PubMed ID: 6723482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]